and the gels/Western Blots that compose the figure are presented. Upper right gel. Coomassie stain after SDS-PAGE separation of E. coli lysate after induction with IPTG (Lane 1 on Figure 1C ). Bottom left gel. Coomassie stain after SDS-PAGE separation of the purified PvRMC-MSP1 separated on a 4-20% gradient gel (Lane 1 and 2 on Figure 1C ). Bottom left western blot. PvRMC-MSP1 incubated with sera samples from mice immunized with a synthetic peptide representing the T cell epitope L 158 -D 177 (Lane 3 Figure 1C ), a synthetic peptide representing the T cell epitope L 378 -S 397 (Lane 4 Figure 1C) , and a synthetic peptide representing the T cell epitope N 78 -L 97 (Lane 5 Figure 1C ). Bottom right western blot. Incubation of PvRMC-MSP1 with the monoclonal antibody 2A10 that recognizes the (NANP) 6 repeat sequence used as a C-terminal tag (Lane 6 Figure 1C ). Figure S2 . Western blot analyses of PvRMC-MSP1 and PvMSP1 19 after SDS-PAGE in reducing and non-reducing conditions. Both PvMSP1 19 (Lanes 2 and 3) and PvRMC-MSP1 (Lanes 5 and 6) were resolved using 5-20% gradient SDS-PAGE and then subject to western blot analysis with α-His tag monoclonal antibody. Reduced conditions are presented on Lanes 3 and 6. The molecular weight markers (Lane 1) are indicated. Data are shown as heat maps generated from predicted scores by the IEDB server for binding to human (A) and mouse (B) MHC class I alleles. Columns indicate amino acid position in PvRMC-MSP1 and in the right, the MHC class I allele are indicated for which the prediction was performed. Peptides predicted to have high affinities (<50nM) in red; medium affinity (>50 to 500 nM) in blue, low affinity (<500 to 5000 nM) in gray and very low to no binding in black (>5000nm). PvRMC-MSP1 is predicted to contain several peptides with medium to high affinity for binding to HLA-A* alleles in the N-terminal and central region. Peptides predicted to have high to medium affinities for HLA-B* are less numerous. Binding of PvRMC-MSP1 peptides to mouse class I alleles is predicted to be more restricted and observed mainly in the first 100 amino acids. Heat maps were generated by using the matrix visualization and analysis platform GENE-E (http://www.broadinstitute.org/cancer/software/GENE-E/index.html). The MHCI binding predictions were made on 12-14-15 using the IEDB analysis resource ANN tool (59, 63, 66, 67) Supplementary Figure S7 . Gating Strategy For Flow Cytometry Analysis. In this sample, gating cells were first gated for singlets (FSC-H vs. FSC-A) and lymphocytes (SSC-A vs. FSC-A). The lymphocyte gate is further analyzed for their uptake of the Live/Dead stain to determine live versus dead cells. After selection of the live population, the CD3 expression was then analyzed to select the T cell population. CD4 and CD8 surface expression were then determined. Intracellular expression of cytokines (IFN-γ, TNF-α, IL-2) was analyzed in each T cell subset. 
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